Ambra Bioscience has a total of 10 patents globally, out of which 6 have been granted. Of these 10 patents, more than 30% patents are active. The United States of America is where Ambra Bioscience has filed the maximum number of patents, followed by Europe (EPO). Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Ambra Bioscience.
Ambra Bioscience was founded in the year 2014. Using a patented gut sensory modulation technology platform, Ambra BioScience produces medical meals and dietary supplements that target critical health and wellness concerns, such as maintaining blood sugar and weight in a healthy range.
Do read about some of the most popular patents of Ambra Bioscience which have been covered by us in this article and also you can find Ambra Bioscience patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ambra Bioscience patent portfolio.
How many patents does Ambra Bioscience have?
Ambra Bioscience has a total of 10 patents globally. These patents belong to 4 unique patent families. Out of 10 patents, 3 patents are active.
How Many Patents did Ambra Bioscience File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Ambra Bioscience Applications Filed | Ambra Bioscience Patents Granted |
2019 | 2 | – |
2018 | – | 3 |
2016 | – | 2 |
2014 | 1 | 1 |
2013 | 1 | – |
2012 | 1 | – |
2011 | 1 | – |
2010 | 4 | – |
How many Ambra Bioscience patents are Alive/Dead?
Worldwide Patents
How Many Patents did Ambra Bioscience File in Different Countries?
Countries in which Ambra Bioscience Filed Patents
Country | Patents |
United States Of America | 5 |
Europe (EPO) | 2 |
Germany | 1 |
Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Ambra Bioscience Patents Located?
The Research Centre for all the Ambra Bioscience patents is the United States of America.
Best Ambra Bioscience Patents
US8828953B2 is the most popular patent in the Ambra Bioscience portfolio. It has received 7 citations so far from companies like Opko Biologics Ltd, Biokier, Inc, and Medibotics Llc
What Percentage of Ambra Bioscience US Patent Applications were Granted?
Ambra Bioscience (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Ambra Bioscience patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Ambra Bioscience?
Law Firm | Total Applications | Success Rate |
Arnold & Porter Kaye Scholer Llp | 5 | 100.0% |
List of Ambra Bioscience Patents
Ambra Bioscience | Title |
US9526741B2 | Chemosensory Receptor Ligand-Based Therapies |
US9486463B2 | Chemosensory Receptor Ligand-Based Therapies |
HK1167615A1 | Chemosensory Receptor Ligand-Based Therapies |
US9901551B2 | Chemosensory Receptor Ligand-Based Therapies |
US8828953B2 | Chemosensory Receptor Ligand-Based Therapies |
US20210084956A1 | Compositions And Methods For Hunger Control And Weight Management |
EP2421524B1 | Chemosensory Receptor Ligand-Based Therapies |
EP2916828A1 | Gras Enteric Coating Formulations And Methods Of Making And Using Same |
WO2019165309A1 | Compositions And Methods For Hunger Control And Weight Management |
DE602010052558T2 | Therapies Based On Chemosensory Receptor Ligands |
What are Ambra Bioscience’s key innovation segments?
What Technologies are Covered by Ambra Bioscience?
The chart below distributes patents filed by Ambra Bioscience